Coexistence of Gaucher Disease and severe congenital neutropenia
| Autor: | Ebru Canda, Hüseyin Onay, Sema Kalkan Uçar, Eser Yıldırım Sözmen, Ferda Ozkinay, Mehtap Kagnici, Melis Köse, Deniz Yilmaz Karapinar, Mahmut Çoker |
|---|---|
| Přispěvatelé: | Ege Üniversitesi |
| Rok vydání: | 2019 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Neutropenia Gaucher disease Disease Bone Marrow Internal medicine medicine Congenital Bone Marrow Failure Syndromes Humans Congenital Neutropenia Molecular Biology Adaptor Proteins Signal Transducing Hematology business.industry GBA gene Infant Cell Biology Enzyme replacement therapy medicine.disease Kostmann syndrome HAX1 gene HAX1 Mutation Molecular Medicine business Rare disease |
| Zdroj: | Blood Cells, Molecules, and Diseases. 76:1-6 |
| ISSN: | 1079-9796 |
| Popis: | WOS: 000461043500001 PubMed ID: 30473482 Gaucher Disease (GD) is the most common lysosomal storage disorder has traditionally been classified into three clinical phenotypes. Type 3 GD is characterized by neurological involvement but neurological symptoms generally appear later in life than in type 2 disease. Neutropenia is much rarer than other hematological manifestations in GD and has not been scrutinized adequately. Severe congenital neutropenia (SCN) is a rare disease entity which is characterized by a paucity of peripherally circulating neutrophils with arrest of neutrophil maturation at the promyelocyte stage and consequent increased susceptibility to severe and recurrent infections. We report a patient who presented in the first year of life with visceral involvement and severe neutropenia in whom the propositus had a unique coexistence of Gaucher Disease and severe congenital neutropenia associated with a mutation in HAX1. In contrast to his expired siblings he had experienced no severe infections. These clinical observations suggest that enzyme replacement therapy may display a modulating factor with respect to the clinical course of SCN. Synopsis: Our patient is the only report of the combination of Gaucher Disease and Kostmann Syndrome in the literature. The clinical course of our patient is not severe when comparing with exitus siblings and other Kostmann Syndrome patients. But when considering the patient's only clinical difference is ERT, this case is very important to emphasise the role of enzyme replacement therapy in bone marrow. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect